Shares Of Glenmark Pharma Surges 4% On Phase 1 Results For Blood Cancer Drug
Mumbai: Glenmark Pharmaceuticals's shares surged over 4 per cent in early trade on December 10 after the company’s announced 83 per cent positive response rate in Phase 1 study of ...